Please login to the form below
Wixela Inhub
This page shows the latest Wixela Inhub news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
GSK’s Advair Diskus faces first generic in US
Analysts predict around $250m in sales for Wixela Inhub this year. ... Mylan’s version of the drug is called Wixela Inhub and it has made it to the market ahead of rivals from the likes of Novartis’ Sandoz unit and Hikma/Vectura,
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Account Supervisor
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Executive
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Genital herpes vaccine candidate heads for human studies
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- FDA advisors say no to empagliflozin in type 1 diabetes
- Novartis makes case for NASH candidate tropifexor
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- AbbVie sells $30bn of bonds ahead of Allergan merger
- RWE Blog 3: Is real-world evidence the holy grail
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
Quick links
Infographics
